JohnDouglasHudsonMD

Neurology • Austin, TX

Sleep Medicine

Founder of Austin Neurological Clinic

Join to view full profile

Dr. Hudson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hudson's full profile

Already have an account?

Office
5508 Parkcrest Dr
Suite 310
Austin, TX 78731
Phone+1 512-420-0951

Fax+1 512-420-9944
Is this information wrong?

Education & Training

University of Iowa Hospitals and ClinicsResidency, Neurology, 1964 - 1967
Methodist Health System DallasInternship, Transitional Year, 1963 - 1964
University of Texas Medical Branch School of MedicineClass of 1963

Certifications & Licensure

TX State Medical License 1963 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Lifetime Achievement Award Texas Neurological Society, 2020

Clinical Trials

Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01
Terminated
Phase 2
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) Start of enrollment: 2013 Nov 01
Unknown status
Not Applicable
12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Completed
Phase 3
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Start of enrollment: 2017 Mar 14
Completed
Phase 3
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain Start of enrollment: 2021 Oct 19
Active, not recruiting
Phase 2, Phase 3
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy Start of enrollment: 2004 Oct 01
Completed
Phase 3
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome Start of enrollment: 2004 Oct 01
Completed
Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine Start of enrollment: 2021 Jun 30
Completed
Phase 3
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Start of enrollment: 2022 Mar 04
Active, not recruiting
Phase 4
Roles: Contact
Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH Start of enrollment: 2022 Dec 28
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW, XP052 Study Group> ;Neurology.
2 citations
Concurrent respiratory resistance training and changes in respiratory muscle strength and sleep in an individual with spinal cord injury: case report
Christopher J Russian, Lyn G. Litchke, John Hudson> ;The Journal of Spinal Cord Medicine. 2011 Jan 1
11 citations
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with mo...
Samir Arora, Beatrice Setnik, Drass Michael, John D. Hudson, R. Clemmer, PharmD Paul Meisner, Glenn C. Pixton, Veeraindar Goli, Kenneth W. Sommerville> ;Journal of Opioid Management. 2014 Nov 1
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
Schweitzer PK, Rosenberg R, Zammit GK, Gotfried M, Chen D, Carter LP, Wang H, Lu Y, Black J, Malhotra A, Strohl KP, TONES 3 Study Investigators> ;American journal of respiratory and critical care medicine.
14 citations
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.
Terri E. Weaver, Christopher L. Drake, Heike Benes, Thomas Stern, James Maynard, Stephen G. Thein, James M. Andry, John D. Hudson, Dan Chen, Lawrence P. Carter, Morgan...> ;Annals of the American Thoracic Society. 2020 Jul 31
8 citations
Pharmacokinetics of rotigotine transdermal system in adolescents with idiopathic restless legs syndrome (Willis–Ekbom disease)
Jan-Peer Elshoff, John D. Hudson, Daniel L. Picchietti, Keith Ridel, Arthur S. Walters, Kimberly Doggett, Kimberly Moran, M. Oortgiesen, Francisco Ramirez, Erwin Schol...> ;Sleep Medicine. 2017 Apr 1
Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.
Figueroa-Bonaparte S, Hudson J, Barresi R, Polvikoski T, Williams T, Töpf A, Harris E, Hilton-Jones D, Petty R, Willis TA, Longman C, Dougan CF, Parton MJ, Hanna MG, Q...> ;J. Neurol. Neurosurg. Psychiatr.. 2016-06-01
10 citations
Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.
Diego Garcia-Borreguero, Richard P. Allen, John D. Hudson, Elisabeth Dohin, Frank Grieger, Kimberly Moran, Erwin Schollmayer, René Smit, John W. Winkelman> ;Current Medical Research and Opinion. 2016 Jan 2
Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW, Escartin A, Byrnes W, Tennigkeit F, Borghs S, Li T, Dedeken P, De Backer M, SP0954 Study Group> ;Seizure. 2015-07-10
10 citations
Assessment of the effects of lacosamide on sleep parameters in healthy subjects
J. Douglas Hudson, Jeffrey T. Guptill, William C. Byrnes, Stephen Yates, Paulette Williams, O'Neill F. D'Cruz> ;Seizure. 2015 Feb 1
Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-cont...
Vinik A, Rosenstock J, Sharma U, Feins K, Hsu C, Merante D, DS5565-A-U201 US Phase II Study Investigators> ;Diabetes care. 2014-09-17
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.
Spaeth M, Alegre C, Perrot S, Wang Y, Guinta DR, Alvarez-Horine S, Russell I, Sodium Oxybate Fibromyalgia Study Group> ;Arthritis research & therapy. 2013-11-11
47 citations
Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome
John W. Winkelman, Richard K. Bogan, Markus H. Schmidt, John D. Hudson, Sarah DeRossett, Christina Hill-Zabala> ;Movement Disorders. 2011 Sep 1
A refined diagnostic algorithm for Bethlem myopathy.
Hicks D, Lampe AK, Barresi R, Charlton R, Fiorillo C, Bonnemann CG, Hudson J, Sutton R, Lochmüller H, Straub V, Bushby K> ;Neurology. 2008-04-01
The effects of position, state of consciousness and drugs on cerebrospinal fluid absorption, estimated by I 125 hippuran resorption.
Wealthall SR, Hudson J, Sherriff S> ;Dev Med Child Neurol Suppl. 1972-01-01
Herpes simplex encephalitis.
McKee AP, Hudson JD, Kimura J, McCormick WF> ;South. Med. J.. 1968-03-01
Join now to see all

Press Mentions

What Is the Best Humidity Level for My CPAP Machine?October 13th, 2021
Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep ApnoeaJuly 22nd, 2023
Incannex Submits Key Application to US FA for IHL-42X for Treatment of Obstructive Sleep ApnoeaJuly 25th, 2023

Professional Memberships

American Academy of Sleep Medicine - AASM
Fellow

JohnDouglasHudsonMD

Dr. Hudson is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.